Exhibit 10.45
AMENDMENT NUMBER 1 TO
HEMOPHILIA THERAPY PHARMACY MANAGEMENT AGREEMENT
This Agreement is made and entered into for the purpose of amending
the Hemophilia Therapy Pharmacy Management Agreement (hereinafter referred to
as the "Agreement") which was entered into May 9, 1997, by and between Texas
Health Pharmaceutical Resources (hereinafter referred to as "THPR") and
Children's Medical Center of Dallas (hereinafter referred to as the
"Company").
WITNESSETH
WHEREAS, Company is an eligible Covered Entity and therefore is able
to access Public Health Service pricing for hemophilia products for certain
of its home hemophilia patients; and
WHEREAS, Company has contracted the performance of certain taska
necessary to provide services to its hemophilia patient population to THPR;
WHEREAS, these services have undergone dramatic changes in the level
of reimbursement from third party payors in the last six months;
NOW THEREFORE, for good and valuable consideration, the receipt and
adequacy of which is hereby acknowledged, the parties hereto agree as follows:
1. Effective January 1, 1998, ("Effective Date") Exhibit B of
Section III (Compensation) be and hereby is amended by deleting the first
paragraph thereof and substituting in the place thereof, the following
sentence:
In exchange for services provided by THPR under
section 1A through IJ of this Agreement, the Company
agrees to pay THPR a monthly fee equal to * of
hemophilia patients including those who are covered
under the Chronically Ill Children's Program, Texas
Medicaid program, the Federal Medicare program and
those covered by private insurance.
2. All other provisions of the Agreement shall remain in full
force and effect except as modified by this Agreement.
IN WITNESS WHEREOF, the undersigned parties hereto have caused this
Agreement to be executed as of the 25 day of February, 1998, to be effective
as set out hereinabove.
CHILDREN'S MEDICAL CENTER OF DALLAS
By: /s/ Xxxxxx X Xxxx
-----------------------------------
Title: President and CEO
-----------------------------------
Address: 0000 Xxxxx Xxxxxx
-----------------------------------
Xxxxxx, XX 00000
-----------------------------------
TEXAS HEALTH PHARMACEUTICAL RESOURCES,
a general partnership
By: NOVA FACTOR, INC.,
a general partner
By: /s/ Xxxxx X Xxxxxxx
-----------------------------------
Title: CEO
-----------------------------------
Address: 0000 Xxxxxxx Xxxxxx Xxxxxxx
-----------------------------------
Xxxxxxx, XX 00000
-----------------------------------
* Omitted information is the subject of a request for confidential treatment
pursuant to Rule 406 under the Securities Act of 1933 and has been filed
separately with the Securities Exchange Commission.
